An aptamer for recognizing the transmembrane protein PDL-1 (programmed death-ligand 1), and its application to fluorometric single cell detection of human ovarian carcinoma cells
Author:
Funder
Mashhad University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Analytical Chemistry
Link
http://link.springer.com/article/10.1007/s00604-017-2436-4/fulltext.html
Reference31 articles.
1. Shan J, Ma Z (2017) A review on amperometric immunoassays for tumor markers based on the use of hybrid materials consisting of conducting polymers and noble metal nanomaterials. Microchim Acta 184(4):969–979
2. Hasanzadeh M, Shadjou N (2017) Advanced nanomaterials for use in electrochemical and optical immunoassays of carcinoembryonic antigen. A Rev Microchimica Acta 184(2):389–414
3. Patel SP, Kurzrock R (2015) PD-L1 expression as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther 14(4):847–856
4. Gettinger S, Herbst RS (2014) B7-H1/PD-1 blockade therapy in non–small cell lung cancer: current status and future direction. Cancer J 20(4):281–289
5. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H (2006) Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 66(7):3381–3385
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PD-L1 DNA aptamers isolated from agarose-bead SELEX;Bioorganic & Medicinal Chemistry Letters;2024-11
2. Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems;International Journal of Nanomedicine;2024-09
3. Aptamer-based sensors for fluid biopsies of protein disease markers;Talanta;2024-08
4. A comprehensive investigation of the biophysical approach for aptamer functionalized nanoparticles in cancer therapy: a review;RSC Pharmaceutics;2024
5. Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges;Cancers;2023-11-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3